Abstract
Aim:
To construct a recombinant adenovirus that can express human spermidine/spermine N1-acetyltransferase (SSAT) and detect its inhibitory effect on colorectal cancer cell growth in vitro.
Methods:
A 516 bp cDNA of SSAT was amplified and cloned into a pGL3-hTERT plasmid. The pGL3-hTERT-SSAT recombinant was digested, and the small fragment was cloned into the shuttle vector pAdTrack. The pAdTrack-hTERT-SSAT plasmids were recombined with pAdEasy-1 vectors in AdEasy-1 cells. Positive clones were selected and transfected into the HEK293 packaging cells (transformed human embryonic kidney cells) after they were linearized by PacI. The process of adenovirus packaging and amplification was monitored by green fluorescent protein (GFP) expression. The SSAT protein levels were determined by Western blotting, and the intracellular polyamine content was detected by reverse-phase high performance liquid chromatography. The MTS (3-(4, 5-dimethylthiaol-2-yl)-5-(3-carboxy-methoxyphenyl)-2-(-4-sulfophenyl)-2H-tetrazolium, inner salt) and colony-forming assays were used to analyze the gene transduction efficiency and effect on the growth of HT-29 and LoVo cells. A viable cell count was used to determine the cell growth with or without exogenous polyamines.
Results:
The GFP expression in 293 cells during virus packing and amplification was observed by fluorescence microscopy. Western blotting results demonstrated that Ad-hTERT-SSAT could increase the expression of SSAT, and consequently, spermidine and spermine were reduced to low levels. The MTS and colony-forming assay results showed that HT-29 and LoVo cell growth were significantly inhibited, and the inhibitory effect could be partially reversed by exogenous spermidine and spermine.
Conclusion:
The successfully constructed recombinant adenovirus Ad-hTERT-SSAT could accelerate polyamine catabolism and inhibit the colorectal cell growth in vitro. It also has therapeutic potential in the treatment of colorectal cancer.
Similar content being viewed by others
Article PDF
References
Porter CW, Regenass U, Bergeron RJ . In: Dowling RH, Folsch UR, Loser C, editors. Falk symposium on polyamines in the gastrointestinal tract; Dordrecht, Netherlands: Kluwer Academic Publishers Group; 1992. p 301–22.
Auvinen M, Paasinen A, Andersson LC, Holtta E . Ornithine decarboxylase activity is critical for cell transformation. Nature 1992; 360: 355–8.
Moshier JA, Dosescu J, Skunca M, Luk GD . Transformation of NIH/3T3 cells by ornithine decarboxylase overexpression. Cancer Res 1993; 53: 2618–22.
Pegg AE, Xiong H, Feith DJ, Shantz LM . S-adenosylmethionine decarboxylase: structure, function and regulation by polyamines. Biochem Soc Trans 1998; 26: 580–6.
Marton LJ, Pegg AE . Polyamines as targets for therapeutic intervention. Annu Rev Pharmacol Toxicol 1995; 35: 55–91.
Glikman P, Vegh I, Pollina MA, Mosto AH, Levy CM . Ornithine decarboxylase activity, prolactin blood levels, and estradiol and progesterone receptors in human breast cancer. Cancer 1987; 60: 2237–43.
Upp JR, Saydjari R, Townsend CM, Singh P, Barranco SC, Thompson JC . Polyamine levels and gastrin receptors in colon cancers. Ann Surg 1988; 207: 662–9.
Gerner EW, Meyskens FL . Polyamines and cancer: old molecules, new understanding. Nat Rev Cancer 2004; 4: 781–92.
Loser C, Folsch UR, Paprotny C, Creutzfeldt W . Polyamines in colorectal cancer. Evaluation of polyamine concentrations in the colon tissue, serum and urine of 50 patients with colorectal cancer. Cancer 1990; 65: 958–66.
Higuchi CM, Wang W . Comodulation of cellular polyamines and proliferation: biomarker application to colorectal mucosa. J Cell Biochem 1995; 57: 256–61.
Hu HY, Liu XX, Jiang CY, Zhang Y, Bian JF, Lu Y, et al. Cloning and expression of ornithine decarboxylase gene from human colorectal carcinoma. World J Gastroenterol 2003; 9: 714–6.
Hu HY, Liu XX, Jiang CY, Lu Y, Liu SL, Bian JF, et al. Ornithine decarboxylase gene is overexpressed in colorectal carcinoma. World J Gastroenterol 2005; 11: 2244–8.
Zhang B, Liu XX, Zhang Y, Jiang CY, Teng QS, Hu HY, et al. Adenovirus-mediated expression of both antisense ODC and AdoMetDC inhibits colorectal cancer cell growth in vitro. Acta Pharmacol Sin 2006; 27: 353–9.
Zhang B, Liu XX, Zhang Y, Jiang CY, Hu HY, Gong L, et al. Polyamine depletion by ODC-AdoMetDC antisense adenovirus impairs human colorectal cancer growth and invasion in vitro and in vivo. J Gene Med 2006; 8: 980–9.
Chi WL, Song XR, Jiang CY, Liu XX, Li WT, Wang XW . Lentiviral vector-mediated downregulation of ornithine decarboxylase inhibits tumor cell growth in vitro and in vivo. Tumor Biol 2006; 27: 243–51.
Vujcic S, Halmekyto M, Diegelman P, Gan G, Kramer DL, Janne J, et al. Effects of conditional overexpression of spermidine/spermine N1-acetyltransferase on polyamine pool dynamics, cell growth, and sensitivity to polyamine analogs. J Biol Chem 2000; 275: 38319–28.
Wallace HM, Caslake R . Polyamines and colon cancer. Eur J Gastroenterol Hepatol 2001; 13: 1033–9.
Casero RA, Pegg AE . Spermidine/spermine N1-acetyltransferase: the turning point in polyamine metabolism. FASEM J 1993; 7: 653–61.
Seiler N . Functions of polyamine acetylation. Can J Physiol Pharmacol 1987; 65: 2024–35.
Marton LJ, Pegg AE . Polyamines as targets for therapeutic intervention. Annu Rev Pharm 1995; 35: 55–91.
Casero RA, Woster PM . Terminally alkylated polyamine analogues as chemotherapeutic agents. J Med Chem 2001; 44: 1–26.
Martin ME, O'Brien TG, Fultz KE, Babbar N, Yerushalmi H, Qu N, et al. Pronounced reduction in adenoma recurrence associated with aspirin use and a polymorphism in the ornithine decarboxylase gene. Proc Natl Acad Sci USA 2003; 100: 7859–64.
Babbar N, Gerner EW, Casero RA . Induction of spermidine/spermine N1-acetyltransferase (SSAT) by aspirin in Caco-2 colon cancer cells. Biochem J 2006; 394: 317–24.
Yi C, Huang Y, Guo ZY, Wang SR . Antitumor effect of cytosine deaminase/5-fluorocytosine suicide gene therapy system mediated by Bifidobacterium infantis on melanoma. Acta Pharmacol Sin 2005; 26: 629–34.
Zhang SN, Yuan SZ, Zhu ZH, Wen ZF, Huang ZQ, Zeng ZY . Apoptosis induced by 5-flucytosine in human pancreatic cancer cells genetically modified to express cytosine deaminase. Acta Pharmacol Sin 2000; 21: 655–9.
Hu YC . Baculovirus as a highly efficient expression vector in insect and mammalian cells. Acta Pharmacol Sin 2005; 26: 405–16.
Li L, He DL . Transfection of promyelocytic leukemia in retrovirus vector inhibits growth of human bladder cancer cells. Acta Pharmacol Sin 2005; 26: 610–5.
Kanerva A, Hemminki A . Modified adenoviruses for cancer gene therapy. Int J Cancer 2004; 110: 475–80.
Author information
Authors and Affiliations
Corresponding author
Additional information
Project supported by the Shandong Province Natural Science Great Item (No Z2004C01) and the Doctoral Foundation of the Ministry of Education (No 20040422029).
Rights and permissions
About this article
Cite this article
Sun, H., Liu, B., Yang, Yp. et al. Adenovirus-mediated expression of SSAT inhibits colorectal cancer cell growth in vitro. Acta Pharmacol Sin 29, 606–613 (2008). https://doi.org/10.1111/j.1745-7254.2008.00779.x
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1111/j.1745-7254.2008.00779.x
Keywords
This article is cited by
-
Anti-colorectal cancer effects of anti-p21Ras scFv delivered by the recombinant adenovirus KGHV500 and cytokine-induced killer cells
BMC Cancer (2018)
-
Molecular characterization of early adenocarcinoma of the uterine cervix by oligonucleotide microarray
Archives of Gynecology and Obstetrics (2011)